TIDMCVSG
RNS Number : 3776K
CVS Group plc
20 December 2022
20 December 2022
CVS Group Plc
("CVS", the "Company" or the "Group")
Exercise of Options, PDMR Dealing, EBT Share Purchase and Total
Voting Rights
CVS, one of the UK's leading providers of integrated veterinary
services, announces that on 19 December 2022, options over a total
of 115,280 new Ordinary shares of 0.2 pence each (the "New shares")
were exercised under the CVS Group 2019 Long Term Incentive Plan
("LTIP 13"), at an exercise price of 0.2 pence.
Richard Fairman, Chief Executive Officer, Ben Jacklin, Chief
Operating Officer, and Robin Alfonso, Chief Financial Officer,
exercised options over 46,296, 27,778 and 15,278 Ordinary shares of
0.2p each in the Company ("Ordinary shares") respectively. The
balance of the options was exercised by certain other employees of
the Company.
On 19 December 2022, the Company was notified by JTC Employer
Solutions Trustee Limited, the trustee of the CVS Group Employee
Benefit Trust (the "EBT"), that the EBT had purchased a total of
60,944 of the New shares from LTIP 13 option-holders at a
volume-weighted average price of GBP20.01 per Ordinary share. This
included the purchase of shares by the EBT from Richard Fairman,
Ben Jacklin and Robin Alfonso to meet the costs of exercise
incurred by them as PDMR option-holders, including personal
taxation, as set out below:
Name Number of shares sold to EBT Price
Richard Fairman 22,159 GBP20.01
Ben Jacklin 13,295 GBP20.01
Robin Alfonso 7,313 GBP20.01
The New shares purchased by the EBT are intended to be used to
satisfy the exercise of share options by employees. The EBT is a
discretionary trust for the benefit of the Company's employees,
including the Directors of the Company. The purchase of the New
shares by the EBT has been funded from the Company's existing cash
reserves. Following this transaction, a total of 60,968 Ordinary
shares are held by the EBT, representing approximately 0.086% of
the Company's total voting rights.
Application has been made for the New shares, which rank pari
passu in all respects with the Company's existing Ordinary shares,
to be admitted to trading on AIM, which is expected to occur on 22
December 2022.
Following the issue of the New shares, the Company has a total
issued share capital of 71,271,971 Ordinary shares each carrying
one voting right. The Company holds no Ordinary shares in treasury.
Therefore, following the issue of the New shares, the total number
of voting rights in the Company will be 71,271,971. This figure may
be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency Rules.
Following their respective option exercises, their sales of a
portion of the New shares arising and admission of the New shares,
the Executive Directors hold a beneficial interest in the following
Ordinary shares in the Company:
Name Number of shares Percentage interest in the Company
Richard Fairman 55,981 0.079%
Ben Jacklin 22,384 0.031%
Robin Alfonso 11,442 0.016%
The notification below, made in accordance with the requirements
of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418
8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Toby Strong +44 (0)7789 151 644
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Richard Fairman
-------------------------- ---------------------------------------------
Reason for the notification
2
-------------------------------------------------------------------------
a) Position/status Chief Executive Officer
-------------------------- ---------------------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------- ---------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
a) Name CVS Group plc
-------------------------- ---------------------------------------------
b) LEI 213800J41XDQ2NX48O05
-------------------------- ---------------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.2 pence each
financial instrument,
type of instrument
GB00B2863827
Identification code
-------------------------- ---------------------------------------------
b) Nature of the transaction i) Exercise of options under LTIP
13
ii) Sale of Ordinary shares arising
from exercise
-------------------------- ---------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
i) Exercise price
of 0.2p 46,296
22,159
ii) 2,000.77p
----------
-------------------------- ---------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
-------------------------- ---------------------------------------------
e) Date of the transaction 19 December 2022
-------------------------- ---------------------------------------------
f) Place of the transaction i) Outside a trading venue
ii) London Stock Exchange, AIM.
-------------------------- ---------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Ben Jacklin
-------------------------- --------------------------------------------
Reason for the notification
2
------------------------------------------------------------------------
a) Position/status Chief Operating Officer
-------------------------- --------------------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------- --------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
------------------------------------------------------------------------
a) Name CVS Group plc
-------------------------- --------------------------------------------
b) LEI 213800J41XDQ2NX48O05
-------------------------- --------------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.2 pence each
financial instrument,
type of instrument
GB00B2863827
Identification code
-------------------------- --------------------------------------------
b) Nature of the transaction i) Exercise of options under LTIP
13
ii) Sale of Ordinary shares arising
from exercise
-------------------------- --------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
i) Exercise price
of 0.2p 27,778
13,295
ii) 2,000.77p
----------
-------------------------- --------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
-------------------------- --------------------------------------------
e) Date of the transaction 19 December 2022
-------------------------- --------------------------------------------
f) Place of the transaction i) Outside a trading venue
ii) London Stock Exchange, AIM.
-------------------------- --------------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Robin Alfonso
-------------------------- --------------------------------------------
Reason for the notification
2
------------------------------------------------------------------------
a) Position/status Chief Financial Officer
-------------------------- --------------------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------- --------------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
------------------------------------------------------------------------
a) Name CVS Group plc
-------------------------- --------------------------------------------
b) LEI 213800J41XDQ2NX48O05
-------------------------- --------------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------
a) Description of the Ordinary shares of 0.2 pence each
financial instrument,
type of instrument
GB00B2863827
Identification code
-------------------------- --------------------------------------------
b) Nature of the transaction i) Exercise of options under LTIP
13
ii) Sale of Ordinary shares arising
from exercise
-------------------------- --------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
i) Exercise price
of 0.2p 15,278
7,313
ii) 2,000.77p
----------
-------------------------- --------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
-------------------------- --------------------------------------------
e) Date of the transaction 19 December 2022
-------------------------- --------------------------------------------
f) Place of the transaction i) Outside a trading venue
ii) London Stock Exchange, AIM.
-------------------------- --------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEEAKAEADXAFFA
(END) Dow Jones Newswires
December 20, 2022 11:38 ET (16:38 GMT)
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
